Pharvaris N.V.PHVSNASDAQ
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank85
3Y CAGR-6.8%
Year-over-Year Change
Year-over-year earnings per share growth rate
3Y CAGR
-6.8%/yr
Quarterly compound
Percentile
P85
Within normal range
vs 3Y Ago
0.8x
Contraction
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 27.71% |
| Q2 2025 | 2.35% |
| Q1 2025 | -32.81% |
| Q4 2024 | 16.88% |
| Q3 2024 | -40.00% |
| Q2 2024 | -5.77% |
| Q1 2024 | 14.75% |
| Q4 2023 | -5.17% |
| Q3 2023 | -2835.85% |
| Q2 2023 | 103.16% |
| Q1 2023 | 42.24% |
| Q4 2022 | -364.00% |
| Q3 2022 | 34.21% |
| Q2 2022 | 20.83% |
| Q1 2022 | -29.73% |
| Q4 2021 | -32.14% |
| Q3 2021 | 39.13% |
| Q2 2021 | -142.11% |
| Q2 2021 | 44.12% |
| Q4 2020 | -70.00% |
| Q3 2020 | -11.11% |
| Q2 2020 | -80.00% |
| Q1 2020 | 9.09% |
| Q4 2019 | -74.05% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | -86.43% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |